Articles From: EUROPE MARKETS: European Stocks: Miners Fall After Soft China Data, OPEC Fallout to European stocks climb ahead of U.S. payrolls data


2014/12/1
By Carla Mozee, MarketWatch European oil E&P has fallen roughly 35% this year LONDON (MarketWatch) -- European stocks fell Monday, with shares of miners struggling after soft economic data from China, and as oil stocks continue to grapple with a stunning slide in oil prices.
Sign-up for EUROPE MARKETS: European Stocks: Miners Fall After Soft China Data, OPEC Fallout investment picks
2014/12/1
By Carla Mozee, MarketWatch European oil E&P has fallen roughly 35% this year LONDON (MarketWatch) -- European stocks fell Monday, with shares of miners struggling after soft economic data from China, and oil stocks still reeling as the sector grapples with the stunning slide in oil prices to fresh multiyear lows.
Sign-up for EUROPE MARKETS: European Stocks: Miners Fall After Soft China Data, OPEC Fallout investment picks
2014/11/25
By Carla Mozee, MarketWatch Dutch bank ING Groep NV said it will cut 1,700 jobs LONDON (MarketWatch) -- European stocks rose Tuesday, with German equities extending gains after data confirmed modest quarterly growth for the eurozone's largest economy.
Sign-up for EUROPE MARKETS: German Economy Logs Modest GDP Growth; Stocks Climb investment picks
2014/11/18
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- German stocks surged to intraday highs Tuesday, bolstered as a closely watched survey indicated the mood in Europe's largest economy appears to have improved.
Sign-up for EUROPE MARKETS: German Stocks Jump, Euro Rises As German Economic Mood Improves investment picks
2014/11/24
By Josie Cox European stocks and bonds rallied in early trade Monday, still encouraged by hints of further stimulus from European Central Bank President Mario Draghi last week and even though data showing stronger than expected German business sentiment may take the edge off expectations for immediate action.
Sign-up for Europe Stocks Rally -- Update investment picks
2014/11/24
By Josie Cox European shares rose tentatively in early trade Monday, still feeling the effects of last week's hints at further stimulus from Mario Draghi.
Sign-up for Europe Stocks Rise on Draghi's Stimulus Hints investment picks
2014/9/29
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks dropped Monday as investors fretted about taking on risk amid contentious pro-democracy protests in Hong Kong against Beijing.
Sign-up for Europe stocks under pressure from Hong Kong, ECB worries investment picks
2014/11/18
By Tommy Stubbington European stocks climbed Tuesday, spurred by signs that the European Central Bank is still on track to take new steps to tackle low inflation.
Sign-up for Europe Stocks Up As Draghi Comments Continue to Buoy Mood investment picks
2014/11/18
European stocks climbed Tuesday, spurred by signs that the European Central Bank is still on track to take new steps to tackle low inflation.
Sign-up for Europe Stocks Up On ECB Comments investment picks
2014/11/18
By Selina Williams LONDON--Shares in many of Europe's battered oil services companies have risen on speculation that a tie-up between U.S. giants Halliburton Co.
Sign-up for Europe's Oil Service Shares Rise on Merger Hopes investment picks
2014/11/19
By Shawn Langlois, MarketWatch Critical intelligence before the U.S. market opens The last time the Fed minutes came around, stocks ignited with their biggest gain of the year, erasing a 273-point implosion the day before.
Sign-up for Europe's potential double-digit rally and a tough act to follow for Fed minutes investment picks
Genzyme , a Sanofi company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of Cerdelga ® (eliglustat) capsules, an oral treatment for certain adults living with Gaucher disease type 1.
Sign-up for European CHMP Adopts Positive Opinion for Genzyme’s Cerdelga® (eliglustat) Capsules investment picks
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company’s Marketing Authorization Application (MAA) for Harvoni ® , an investigational once-daily tablet combining the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg, for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Sign-up for European CHMP Adopts Positive Opinion for Gilead’s Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults investment picks
BENTON HARBOR, Mich.
Sign-up for European Commission Approves Whirlpool's Acquisition of Indesit investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the European Commission has granted marketing authorization for Harvoni ® (ledipasvir 90 mg/sofosbuvir 400 mg), the first once-daily single tablet regimen to treat the majority of chronic hepatitis C genotype 1 and 4 infection in adults.
Sign-up for European Commission Grants Marketing Authorization for Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4 investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the European Commission has granted marketing authorization for Zydelig ® (idelalisib), 150 mg tablets, a first-in-class oral treatment for two incurable blood cancers - chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). For the treatment of CLL, Zydelig has been approved for use in combination with rituximab for patients who have received at least one prior therapy; or as first-line treatment in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
Sign-up for European Commission Grants Marketing Authorization for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma investment picks
2014/9/16
Technology has made it easier than ever for companies to manage the complex web of trading partners around the globe on whom their business increasingly depends.
Sign-up for European Companies Ill-Prepared to Support Business Collaboration investment picks
2014/11/21
By Sam Schechner Some European legislators, backed by members the German government, are preparing a draft resolution calling for the breakup of Google Inc.--a political salvo that could add to pressure on the European Union's newly appointed executive arm to crack down on the Internet giant.
Sign-up for European Critics Envision Google's 'Unbundling' investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Medicines Agency (EMA) has validated and initiated its review of the company’s marketing authorization application (MAA) for Natpar ® (parathyroid hormone (rDNA)) for the treatment of Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone (PTH). If approved, Natpar would be the first and only PTH replacement therapy in Europe for patients with Hypoparathyroidism.
Sign-up for European Medicines Agency Validates Marketing Authorization Application for Natpar® (parathyroid hormone (rDNA)) in Hypoparathyroidism investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for nivolumab in non-small cell lung cancer (NSCLC) – the first completed regulatory submission for a PD-1 immune checkpoint inhibitor in this tumor type.
Sign-up for European Medicines Agency Validates the Marketing Authorization Application for Nivolumab in Non-Small Cell Lung Cancer investment picks
2014/11/19
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Mining stocks suffered in European trading Wednesday, limiting gains on the pan-European index after a two-session run of advances.
Sign-up for European mining shares struggle on drop in iron-ore prices investment picks
2014/12/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks fell Monday, with shares of natural-resource producers struggling after soft economic data from China and a fresh selloff in oil prices.
Sign-up for European mining stocks fall after soft China data; oil stocks extends losses investment picks
2014/9/22
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Mining stocks led losses in Europe on Monday on concerns that China, a major natural-resources buyer, will tolerate slower economic growth, but Merck KGaA outperformed following the German company's agreement to buy life-science company Sigma-Aldrich, a U.S. company.
Sign-up for European mining stocks hurt by China growth worries investment picks
2014/11/28
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks fell Friday, with oil stocks hit hard in the wake of a decision by the Organization of the Petroleum Exporting Countries not to cut its oil-production target.
Sign-up for European oil stocks hit as OPEC holds production target investment picks
2014/10/9
U.K. and Continental Natural Gas Prices Also Rose Month over Month LONDON , Oct.
Sign-up for European Power Prices up 35% as Bear Run Broke in September investment picks
http://media.marketwire.com/attachments/201006/8013_kosslogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153432&ProfileId=051205&sourceType=1 MILWAUKEE, WI --
Sign-up for European Sales Continue to Sag as Koss Reports Quarterly Results investment picks
2014/11/19
By Tommy Stubbington European shares ended the session broadly unchanged Wednesday, as investors weighed upbeat economic data from earlier in the week against a lasting slump in commodity prices, particularly burdening miners.
Sign-up for European Shares Broadly Unchanged -- 3rd Update investment picks
2014/10/27
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European banks rallied at the open on Monday after the European Central Bank and the European Banking Authority said most of the region's lenders passed stress tests.
Sign-up for European stocks climb after stress-tests results investment picks
2014/11/7
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets headed for weekly gains on Friday, with investors hoping the highly anticipated U.S. jobs data will give them more to cheer about, after a dovish European Central Bank sent markets higher yesterday.
Sign-up for European stocks climb ahead of U.S. payrolls data investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: EUROPE MARKETS: European Stocks: Miners Fall After Soft China Data, OPEC Fallout to European stocks climb ahead of U.S. payrolls data
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent